Newsletters
The Capitalist Newsletter – January 6, 2017
CARNIVAL CRUISE LINES INTRODUCES WEARABLE TECH; LOOKS TO TRANSFORM CRUISE EXPERIENCE |
|
Winners & Losers – EnteroMedics, Inc. (ETRM) Jumps UP (89.95%) After the Company’s Treatment for Obesity, Metabolic Diseases, and Other Gastrointestinal Disorders was Implemented at Two Additional Institutes – Kohl’s Corp. (KSS) Tumbles DOWN (19.02%) After Company’s Dismal Holiday Sales Cast Gloom Over Sector
Most Talked About Genocea Biosciences, Inc. (GNCA) an Overwhelming Strong Buy Following Positive Phase 2 Drug Trial Results
The TIP Sheets – Thursday, January 5th – Halozyme Therapeutics, Inc. (HALO) Pops UP (17.96%) After Anouncing Stellar Phase 2 Results for Pancreatic Cancer Drug Trial. As the Company Prepares for Phase 3, Look for Shares to Continue UP
Unusual Volume
– Macy’s, Inc. (M) Tumbles DOWN Another (13.9%) on 29.5m Shares Traded Following its Dismal Holiday Shares. Combined with Doubt Over the Entire Sector Competing with Online Retailers, Expect Shares to Continue DOWN |